NCT05848609 Functional Status and Quality of Life in Older Patients Undergoing Robotic Surgery for Colorectal Cancer
| NCT ID | NCT05848609 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitair Ziekenhuis Brussel |
| Condition | Colorectal Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-03-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2023-03-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study evaluates prospectively the impact of robotic surgery on functional outcome and quality of life in older patients that are operated for colorectal cancer;
Eligibility Criteria
Inclusion Criteria: * patients ≥ 70 years with colorectal cancer * eligible for colorectal surgery after multidisciplinary board evaluation and patient consent Exclusion Criteria: * decline in cognitive function after geriatric evaluation * emergency surgery * life expectancy \< 3 months
Contact & Investigator
Daniel Jacobs-Tulleneers-Thevissen, MD, PhD
PRINCIPAL INVESTIGATOR
Universitair Ziekenhuis Brussel
Frequently Asked Questions
Who can join the NCT05848609 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Colorectal Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05848609 currently recruiting?
Yes, NCT05848609 is actively recruiting participants. Contact the research team at ellen.vaneetvelde@uzbrussel.be for enrollment information.
Where is the NCT05848609 trial being conducted?
This trial is being conducted at Brussels, Belgium, Jette, Belgium.
Who is sponsoring the NCT05848609 clinical trial?
NCT05848609 is sponsored by Universitair Ziekenhuis Brussel. The principal investigator is Daniel Jacobs-Tulleneers-Thevissen, MD, PhD at Universitair Ziekenhuis Brussel. The trial plans to enroll 120 participants.